| A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance K Skivington, L Matthews, SA Simpson, P Craig, J Baird, JM Blazeby, ... bmj 374, 2021 | 3528 | 2021 |
| Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update K Skivington, L Matthews, SA Simpson, P Craig, J Baird, JM Blazeby, ... Health technology assessment (Winchester, England) 25 (57), 1, 2021 | 403 | 2021 |
| Financial incentives for smoking cessation in pregnancy: randomised controlled trial D Tappin, L Bauld, D Purves, K Boyd, L Sinclair, S MacAskill, J McKell, ... Bmj 350, 2015 | 239 | 2015 |
| 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial TJ Iveson, RS Kerr, MP Saunders, J Cassidy, NH Hollander, J Tabernero, ... The Lancet Oncology 19 (4), 562-578, 2018 | 204 | 2018 |
| The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. J Brush, K Boyd, F Chappell, F Crawford, M Dozier, E Fenwick, J Glanville, ... Health Technology Assessment (Winchester, England) 15 (35), 1, 2011 | 187 | 2011 |
| Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial S Cunningham, A Rodriguez, T Adams, KA Boyd, I Butcher, B Enderby, ... The Lancet 386 (9998), 1041-1048, 2015 | 170 | 2015 |
| One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services L Bauld, KA Boyd, AH Briggs, J Chesterman, J Ferguson, K Judge, ... Nicotine & tobacco research 13 (2), 135-145, 2011 | 101 | 2011 |
| Are financial incentives cost‐effective to support smoking cessation during pregnancy? KA Boyd, AH Briggs, L Bauld, L Sinclair, D Tappin Addiction 111 (2), 360-370, 2016 | 86 | 2016 |
| Intelligent liver function testing (iLFT): a trial of automated diagnosis and staging of liver disease in primary care JF Dillon, MH Miller, EM Robinson, A Hapca, M Rezaeihemami, ... Journal of hepatology 71 (4), 699-706, 2019 | 71 | 2019 |
| Bronchiolitis of Infancy Discharge Study (BIDS) group. Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial S Cunningham, A Rodriguez, T Adams, KA Boyd, I Butcher, B Enderby, ... Lancet 386 (9998), 1041-1048, 2015 | 71 | 2015 |
| Options for producing a warm-water fish in the UK: limits to “Green Growth”? DC Little, FJ Murray, E Azim, W Leschen, K Boyd, A Watterson, JA Young Trends in Food Science & Technology 19 (5), 255-264, 2008 | 69 | 2008 |
| Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation O Wu, K Boyd, J Paul, E McCartney, M Ritchie, D Mellon, L Kelly, ... British journal of cancer 114 (9), 979-985, 2016 | 61 | 2016 |
| Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial J Ferguson, G Docherty, L Bauld, S Lewis, P Lorgelly, KA Boyd, ... Bmj 344, 2012 | 61 | 2012 |
| Cost‐effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow KA Boyd, AH Briggs Addiction 104 (2), 317-325, 2009 | 60 | 2009 |
| Towards integration of environmental and health impact assessments for wild capture fishing and farmed fish with particular reference to public health and occupational health … A Watterson, D Little, JA Young, K Boyd, E Azim, F Murray International Journal of Environmental Research and Public Health 5 (4), 258-277, 2008 | 39 | 2008 |
| 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. T Iveson, KA Boyd, RS Kerr, J Robles-Zurita, MP Saunders, AH Briggs, ... Health Technology Assessment (Winchester, England) 23 (64), 1, 2019 | 30 | 2019 |
| SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer J Robles-Zurita, KA Boyd, AH Briggs, T Iveson, RS Kerr, MP Saunders, ... British journal of cancer 119 (11), 1332-1338, 2018 | 29 | 2018 |
| Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation K Boyd, E McIntosh Health Technology Assessment 19 (71), 1-172, 2015 | 28 | 2015 |
| Scoping a public health impact assessment of aquaculture with particular reference to Tilapia in the UK A Watterson, D Little, JA Young, F Murray, L Doi, KA Boyd, E Azim International Scholarly Research Notices 2012 (1), 203796, 2012 | 27 | 2012 |
| Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): A prospective cohort study and individual … SJ Stock, M Horne, M Bruijn, H White, KA Boyd, R Heggie, L Wotherspoon, ... PLoS medicine 18 (7), e1003686, 2021 | 26 | 2021 |
